Related references
Note: Only part of the references are listed.No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy
T. Bschor et al.
ACTA PSYCHIATRICA SCANDINAVICA (2010)
Regarding “Comprehensive Analysis of Remission (COMPARE) with Venlafaxine Versus SSRIs”
Markus Koesters et al.
BIOLOGICAL PSYCHIATRY (2009)
The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression
Michael Bauer et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis
W. W. van den Broek et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani et al.
LANCET (2009)
Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety
D. Taylor
ACTA PSYCHIATRICA SCANDINAVICA (2008)
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs
Charles B. Nemeroff et al.
BIOLOGICAL PSYCHIATRY (2008)
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder
David G. S. Perahia et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Selective publication of antidepressant trials and its influence on apparent efficacy
Erick H. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
Kerry Dwan et al.
PLOS ONE (2008)
Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis
Kirby Lee et al.
PLOS MEDICINE (2008)
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
Kristin Rising et al.
PLOS MEDICINE (2008)
Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis
S. Weinmann et al.
PSYCHOPHARMACOLOGY (2008)
Duloxetine does not relieve painful physical symptoms in depression: A meta-analysis
Glen I. Spielmans
PSYCHOTHERAPY AND PSYCHOSOMATICS (2008)
The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: Outcomes from the acute and continuation phases
Martin B. Keller et al.
BIOLOGICAL PSYCHIATRY (2007)
Efficacy of duloxetine and selective serotonin reuptake inhibitors - Comparisons as assessed by remission rates in patients with major depressive disorder
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial
Rob M. Kok et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: A Randomized controlled trial
Stephan Brecht et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity
T. N. Wise et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial
Joel Raskin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil
Phil Lee et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2007)
Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study
Gerdine A. J. Fransen et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients
Charles B. Nemeroff et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
Andrew A. Nierenberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
A meta-analysis of clinical trials comparing milnacipran, a serotonin-norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder
George I. Papakostas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Differential antidepressant symptom efficacy: Placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram)
Craig H. Mallinckrodt et al.
NEUROPSYCHOBIOLOGY (2007)
Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder
Arif Khan et al.
CLINICAL DRUG INVESTIGATION (2007)
A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia
Ulisses Gabriel de Vasconcelos Cunha et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort
Jari Tiihonen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Beyond remission: Rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two years (PREVENT) study
Susan G. Kornstein
CNS SPECTRUMS (2006)
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder
Richard C. Shelton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
D. G. S. Perahia et al.
EUROPEAN PSYCHIATRY (2006)
A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression
A Schatzberg et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons
Laurent Eckert et al.
BMC PSYCHIATRY (2006)
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression
Sara A. Corya et al.
DEPRESSION AND ANXIETY (2006)
Duloxetine for the treatment of major depressive disorder: A closer look at efficacy and safety data across the approved dose range
Craig H. Mallinckrodt et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2006)
Randomized trial of sertraline versus venlafaxine XR in major depression: Efficacy and discontinuation symptoms
A Sir et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder
SK Brannan et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
SNRIs: The pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants
SM Stahl et al.
CNS SPECTRUMS (2005)
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data
CJ Whittington et al.
LANCET (2004)
A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder
RJ Bielski et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
Duloxetine in the treatment of depression - A double-blind-placebo-controlled comparison with paroxetine
DJ Goldstein et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
MJ Detke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder
SA Montgomery et al.
NEUROPSYCHOBIOLOGY (2004)
Practical clinical trials - Increasing the value of clinical research for decision making in clinical and health policy
SR Tunis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
H Melander et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Comparative efficacy between venlafaxine and SSRIs: A pooled analysis of patients with depression
SM Stahl et al.
BIOLOGICAL PSYCHIATRY (2002)
Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data
NA Buckley et al.
BRITISH MEDICAL JOURNAL (2002)
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression
MJ Detke et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2002)
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis
D Smith et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial
MJ Detke et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Duloxetine in the treatment of major depressive disorder: A double-blind clinical trial
DJ Goldstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
M Zimmerman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
ME Thase et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder
OP Mehtonen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia
M Tzanakaki et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2000)
Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia
V Gentil et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2000)
Share Paper
